1. (1) As used in this section:

   1. (a) “HIV test” has the meaning given that term in ORS 433.045.
   2. (b) “Post-exposure prophylactic antiretroviral therapy” means a drug or other therapy intended to reduce the likelihood of the acquisition of human immunodeficiency virus following a possible exposure to human immunodeficiency virus.
   3. (c) “Preexposure prophylactic antiretroviral therapy” means a drug or other therapy intended to prevent the acquisition of human immunodeficiency virus.

2. (2) A pharmacist may prescribe, dispense and administer:

   1. (a) Preexposure prophylactic antiretroviral therapies; and
   2. (b) In accordance with any rules adopted by the State Board of Pharmacy under ORS 689.645, post-exposure prophylactic antiretroviral therapies.

3. (3)

   1. (a) A pharmacist may perform an HIV test or may order an HIV test performed by a laboratory. A laboratory that performs an HIV test ordered under this subsection shall submit the results of the HIV test to the pharmacist who ordered the test.
   2. (b) A pharmacist who orders or performs an HIV test under this subsection shall comply with the requirements of ORS 433.045.
4. (4) The State Board of Pharmacy shall adopt rules to carry out this section. The rules adopted under this subsection must allow a pharmacist to prescribe, dispense and administer up to a 30-day supply of a preexposure prophylactic antiretroviral therapy to a patient based solely on the pharmacist’s interpretation that the results of an HIV test administered under this section indicate the patient is HIV-negative.

[2021 c.365 §2]